Browse Data and Analysis
Filter
Search Data and Analysis
- 11 results found
- (-) Guinea
- (-) Israel
- (-) New Technologies
- Clear all
This is a regional report on West Africa that primarily covers Senegal, Burkina Faso, and Mali, but also provides brief overviews in certain sections for Niger, The Gambia, Guinea, Guinea-Bissau, and Mauritania.
Israel does not have a policy restricting the use of imported genetically engineered (GE) commodities or derivative products. There are no changes in Israel’s policy towards plant, animal biotechnology, and microbial biotechnology since 2023.
Israel has no policy restricting the use of imported genetically engineered (GE) commodities or derivative products. There have been no changes in Israel’s policy towards plant, animal biotechnology, and microbial biotechnology since 2022.
As of September 2022, Israel does not have a policy restricting the use of imported genetically engineered (GE) commodities or derivative products. There are no changes in Israel’s policy towards plant, animal biotechnology, and microbial biotechnology compared to 2021.
As of October 2021, Israel does not have a policy restricting the use of imported genetically engineered (GE) commodities or derivative products. There are no changes in Israel’s policy towards plant, animal biotechnology, and microbial biotechnology...
As of September 2020, Israel does not have a policy restricting the use of imported genetically engineered (GE) commodities or derivative products.
As of October 2019, there are no changes in Israel’s policy towards plant and animal biotechnology compared to 2018.
As of October 2018, Israel does not have a policy that restricts the use of imported genetically engineered (GE) commodities or derivative products.
As of June, 2017, Israel does not have a policy that restricts the use of imported genetically engineered (GE) commodities or derivative products.
As of July 2016, Israel does not have a policy that restricts the use of imported genetically engineered (GE) commodities or derivative products.
As of July 2015, Israel does not have a policy that restricts the use of imported biotech commodities or derivative products.